Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?

Pediatrics

Volumn 105, Issue 6, 2000, Pages 1194-1201

  Van Marter, Linda J ^a,b,f   Allred, Elizabeth N ^a,g   Pagano, Marcello ^a,g   Sanocka, Ulana ^d,e   Parad, Richard ^a,b,f   Moore, Marianne ^a,b,f   Susser, Mervyn ^d   Paneth, Nigel ^c   Leviton, Alan ^a,b   Hegyi, Thomas ^h   Hiatt, Mark ^h   Shahrivar, Farrokh ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h Babies' and Children's Hospital ^*

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Diseases; Epidemiology; Mechanical ventilation; Newborn infant; Premature; Respiratory diseases

Indexed keywords

LUNG SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BAROTRAUMA; CASE CONTROL STUDY; CHRONIC LUNG DISEASE; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OXYGEN THERAPY; OXYGEN TOXICITY; PREVALENCE; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT;

EID: 17144451355     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.6.1194     Document Type: Article

References (37)

1. Hack M, Friedman H, Fanaroff AA. Outcomes of extremely low birth weight infants. Pediatrics. 1996;98:931-937
2. Fanaroff AA, Wright LL, Stevenson DK, et al. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am J Obstet Gynecol. 1995;173:1423-1431
3. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987;79:26-30
4. Horbar JD, McAuliffe TL, Adler SM. Variability in 28-day outcomes for very low birth weight infants: an analysis of 11 neonatal intensive care units. Pediatrics. 1988;82:554-559
5. Van Marter LJ, Leviton A, Kuban KCK, Pagano M, Allred EN. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990;86:331-336
6. Palta M, Gabbert D, Weinstein MR, Peter ME. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J Pediatr. 1991;119:285-292
7. Van Marter LJ, Leviton A, Allred EN, Pagano M, Kuban KCK. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr. 1990;116:942-949
8. Corcoran JD, Patterson CC, Thomas PS, Halliday HL. Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: results of a multivariate logistic regression analysis. Eur J Pediatr. 1993;152:677-681
9. Garland JS, Buck RK, Allred EN, Leviton A. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med. 1995;149:617-622
10. Kraybill EN, Runyan DK, Bose CL, Khan JH. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr. 1989;115:115-120
11. Leviton A, Paneth N, Reuss ML, et al. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics 1997;99(4). URL: http://www.pediatrics.org/cgi/ content/full/99/4/e2
12. The Developmental Epidemiology Network Investigators. The correlation between placental pathology and intraventricular hemorrhage in the preterm infant. Pediatric Res. 1998;43:15-19
13. Miettinen O. Theoretical Epidemiology. New York, NY: John Wiley and Sons; 1985:40
14. Doyle L, Kitchen W, Ford G, et al. Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr. 1986;108:287-292
15. Van Marter LJ, Leviton A, Kuban KCK, Pagano M, Allred E. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990;86:331-336
16. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med. 1967; 276:357-368
17. Ryan SW, Wild NJ, Arthur RJ, Shaw BNJ. Prediction of chronic neonatal lung disease in very low birthweight neonates using clinical and radiological variables. Arch Dis Child. 1994;71:F36-F39
18. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532
19. Philip AGS. Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics. 1975;55:44-50
20. Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics. 1990;86:728-736
21. Van Lierde S, Smith J, Devlieger H, Eggermont E. Outcome of respiratory distress syndrome at 28 days: a prospective longitudinal study. Eur Respir J. 1992;5:1243-1248
22. Moylan FMB, Walker AM, Kramer SS, Todres D, Shannon DC. Alveolar rupture as an independent predictor of bronchopulmonary dysplasia. Crit Care Med. 1978;6:10-13
23. Jobe A, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev. 1998;53:81-94
24. Hislop AA, Wigglesworth JS, Desai R, Aber V. the effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev. 1987;15:147-64
25. Schmidt B, Davis P, La Pointe H, et al. Thrombin inhibitors reduce intrapulmonary accumulation of fibrinogen and procoagulant activity of bronchoalveolar lavage fluid during acute lung injury inducted by pulmonary overdistention in newborn piglets. Pediatr Res. 1996;39: 798-804
26. Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 1995;126:605-610
27. Poets CF, Sens B, Changes in intubation rates and outcome of very low birth weight infants: a population-based study. Pediatrics. 1996;98:24-27
28. Wung JT, Koons AH, Driscoll JM Jr, James LS. Changing incidence of bronchopulmonary dysplasia. J Pediatr. 1979;95:845-847
29. Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants: a pilot study. Pediatr Res. 1997;41:163A
30. Bhutani VK, Abbasi S. Relative likelihood of bronchopulmonary dysplasia based on pulmonary mechanics measured in preterm neonates during the first week of life. J Pediatr. 1992;120:605-613
31. Miettinen O. Efficacy of therapeutic practice: will epidemiology provide the answers? In: Melmon KL, ed. Drug Therapeutics Concepts for Physicians. New York, NY: Elsevier; 1981:201-208
32. Sanchez PJ, Regan JA. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J. 1988;7:542-546
33. Cassell GH, Waites KB, Crouse DT, et al. Association of ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 1988;2: 240-245
34. Tyson J, Wright L, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med. 1999;340:1962-1968
35. Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics. 1993;91:617-623
36. Tarnow-Mordi W, Ogston S, Wilkinson AR, et al. Predicting death from initial disease severity in very low birth weight infants: a method for comparing the performance of neonatal units. Br Med J. 1990;300: 1611-1614
37. Weisberger SA, Richardson DK, Allred EN, et al. Oxygen dependence at 36 weeks in very premature neonates: variation among NTCUs as related to initial illness severity. Pediatr Res. 1998;43:234A